OPKO HEALTH

OPKO Health, Inc. is a multi-national pharmaceutical and diagnostics company that aims to establish industry-leading positions in large and rapidly growing medical markets by leveraging its discovery, development, and commercialization expertise and its novel and proprietary technologies. The company intends to leverage its global commercialization expertise to pursue acquisitions of commercial businesses that will both drive growth and provide geographically diverse sales and distribution opportunities. OPKO has and may continue to make investments in other early stage companies that the company perceives to have valuable proprietary technology and significant potential to create value for OPKO as a shareholder.
OPKO HEALTH
Industry:
Biotechnology Health Diagnostics Pharmaceutical
Founded:
2005-01-01
Address:
Miami, Florida, United States
Country:
United States
Website Url:
http://www.opko.com
Total Employee:
501+
Status:
Active
Contact:
+113055754100
Email Addresses:
[email protected]
Total Funding:
206 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Google Universal Analytics Domain Not Resolving Euro IPv6 ReCAPTCHA
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Radius Health
Radius Health develops drug therapies for osteoporosis and womenโs health.
Scholar Rock
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2022-05-09 | ModeX Therapeutics | ModeX Therapeutics acquired by OPKO Health | N/A |
2016-06-30 | Transition Therapeutics | Transition Therapeutics acquired by OPKO Health | 60 M USD |
2015-06-05 | Bio-Reference Laboratories | Bio-Reference Laboratories acquired by OPKO Health | 1.47 B USD |
2015-05-06 | EirGen Pharma | EirGen Pharma acquired by OPKO Health | 135 M USD |
2014-04-17 | Inspiro Medical | Inspiro Medical acquired by OPKO Health | N/A |
2013-04-24 | PROLOR Biotech | PROLOR Biotech acquired by OPKO Health | N/A |
2013-01-08 | Cytochroma | Cytochroma acquired by OPKO Health | N/A |
2011-10-13 | Claros Diagnostics | Claros Diagnostics acquired by OPKO Health | N/A |
2008-05-06 | Vidus Ocular | Vidus Ocular acquired by OPKO Health | N/A |
2007-03-27 | Acuity Pharmaceuticals | Acuity Pharmaceuticals acquired by OPKO Health | N/A |
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2021-11-10 | HealthSnap | OPKO Health investment in Venture Round - HealthSnap | 5 M USD |
2017-08-02 | Eloxx | OPKO Health investment in Series C - Eloxx | 8 M USD |
2016-12-16 | Phio Pharmaceuticals | OPKO Health investment in Post-IPO Equity - Phio Pharmaceuticals | 10.4 M USD |
2016-07-05 | VBI Vaccines | OPKO Health investment in Post-IPO Equity - VBI Vaccines | 13.61 M USD |
2016-01-13 | Arno Therapeutics | OPKO Health investment in Post-IPO Equity - Arno Therapeutics | 7.4 M USD |
2010-11-04 | Fabrus | OPKO Health investment in Venture Round - Fabrus | 2 M USD |
Official Site Inspections
http://www.opko.com Semrush global rank: 1.68 M Semrush visits lastest month: 14.48 K
- Host name: 45.60.169.160
- IP address: 45.60.169.160
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago

More informations about "OPKO Health"
Company :: OPKO Health, Inc. (OPK)
OPKO Healthโs senior leadership team has worked together for many years, both at OPKO and at other companies, with a strong track record of successfully building innovative healthcare companies and increasing shareholder value. โฆSee details»
Company Information :: OPKO Health, Inc. (OPK)
Company Contact OPKO Health, Inc. 4400 Biscayne Boulevard Miami, FL 33137 T: 305-575-4100 [email protected]See details»
OPKO Health - Wikipedia
OPKO Health, Inc. is a medical test and medication company focused on diagnostics and pharmaceuticals. The company is a publicly traded company on NASDAQ and TASE under the symbol "OPK". See details»
OPKO Health - Crunchbase Company Profile & Funding
OPKO Health, Inc. is a multi-national pharmaceutical and diagnostics company that aims to establish industry-leading positions in large and rapidly growing medical markets by leveraging its discovery, development, and โฆSee details»
OPKO Health, Inc. (OPK) Company Profile & Facts - Yahoo Finance
See the company profile for OPKO Health, Inc. (OPK) including business summary, industry/sector information, number of employees, business summary, corporate governance, โฆSee details»
OPKO Health Company Description - Stock Analysis
3 days ago Company profile for OPKO Health, Inc. (LON: 0KCS) with a description, list of executives, contact details and other key facts.See details»
Opko Health - Craft
Oct 29, 2024 OPKO Health is a multi-national pharmaceutical and diagnostics company that aims to establish industry-leading positions in large and rapidly growing medical markets by โฆSee details»
OPKO Health - Funding, Financials, Valuation & Investors
OPKO Health 's most notable exits include Phio Pharmaceuticals, VBI Vaccines, and VBI Vaccines. OPKO Health has acquired 11 organizations. Their most recent acquisition was โฆSee details»
Leadership :: OPKO Health, Inc. (OPK)
Previously, Mr. Paganelli served as OPKO's Interim CEO and secretary, and Chairman of OPKO's Board of Directors until 2007. Mr. Paganelli also served as President and CEO of Transamerica Life Insurance Company of New York. โฆSee details»
Careers - OPKO Health, Inc., Renal Division
The OPKO Renal Division remains dedicated to recruiting quality, high performing individuals, whose personal and professional goals are aligned with the corporate vision of providing better โฆSee details»
Internal information system - Opkoeurope
OPKO Health Company is committed to always doing the right thing. That is why our organization has an ethics and compliance program supported by the OPKO Code of Business Conduct โฆSee details»
OPKO Health - Contacts, Employees, Board Members, Advisors
OPKO Health has 5 current employee profiles, including CEO, Renal Division Charles Bishop. OPKO Health has 1 board member or advisor, Phillip Frost . ContactsSee details»
OPKO Health, Inc. (LON: 0KCS) - Stock Analysis
6 days ago OPKO Health and HealthCare Royalty Enter into $250 Million Note Purchase Agreement Secured by NGENLA's Profit Share Payments. MIAMI, July 17, 2024 (GLOBE โฆSee details»
Corporate Governance :: OPKO Health, Inc. (OPK)
Previously, Mr. Paganelli served as OPKO's Interim CEO and secretary, and Chairman of OPKO's Board of Directors until 2007. Mr. Paganelli also served as President and CEO of โฆSee details»
With 50% ownership, OPKO Health, Inc. (NASDAQ:OPK) insiders โฆ
Oct 17, 2024 Every investor in OPKO Health, Inc. should be aware of the most powerful shareholder groups. We can see that individual insiders own the lion's share in the company โฆSee details»
Working At OPKO Health: Company Overview and Culture - Zippia
Mar 14, 2024 53% of OPKO Health employees are women, while 47% are men. The most common ethnicity at OPKO Health is White (53%). 18% of OPKO Health employees are โฆSee details»
OPKO Biologics - Crunchbase Company Profile & Funding
OPKO Biologics is a clinical-stage company developing next-generation, bio-better, long-acting versions of therapeutic proteins, and peptide drugs, utilizing CTP, and reversible PEGylation โฆSee details»
OPKO Health - Overview, News & Similar companies - ZoomInfo
May 9, 2024 OPKO Health to Report Second Quarter 2024 Financial Results on August 7, 2024 MIAMI, Aug. 01, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to โฆSee details»
Board Committees :: OPKO Health, Inc. (OPK)
Previously, Mr. Paganelli served as OPKO's Interim CEO and secretary, and Chairman of OPKO's Board of Directors until 2007. Mr. Paganelli also served as President and CEO of โฆSee details»
OPKO Health Statistics - Stock Analysis
6 days ago OPKO Health has a market cap or net worth of GBP 790.00 million. The enterprise value is 879.65 million. Market Cap: 790.00M: Enterprise Value : 879.65M: Important Dates. โฆSee details»